PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.68%
Revenue growth of 4.68% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
7.34%
Gross profit growth of 7.34% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
14.18%
Positive EBIT growth while Healthcare median is negative. Peter Lynch might see a strong competitive advantage in operations.
14.18%
Positive operating income growth while Healthcare is negative. Peter Lynch would spot a big relative advantage here.
28.60%
Positive net income growth while Healthcare median is negative. Peter Lynch would view this as a notable competitive advantage.
28.61%
Positive EPS growth while Healthcare median is negative. Peter Lynch might see a strong advantage in per-share earnings compared to peers.
28.61%
Positive diluted EPS growth while Healthcare median is negative. Peter Lynch might see a real advantage in how this firm manages share count or drives net income.
-0.00%
Share reduction while Healthcare median is 0.00%. Seth Klarman would see a relative advantage if others are diluting.
-0.00%
Diluted share reduction while Healthcare median is 0.00%. Seth Klarman would see an advantage if others are still diluting.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
28.80%
10Y CAGR of 28.80% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
48.70%
5Y CAGR of 48.70% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
22.33%
3Y CAGR of 22.33% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
63.58%
Net income/share CAGR of 63.58% while Healthcare median is zero. Walter Schloss might see a marginal edge that can grow if the firm invests wisely.
18.88%
Net income/share CAGR of 18.88% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand mid-term.
12.08%
3Y net income/share CAGR of 12.08% while Healthcare median is zero. Walter Schloss might see a small advantage that can be scaled further.
161.83%
Equity/share CAGR exceeding 1.5x Healthcare median of 58.81% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
104.73%
5Y equity/share CAGR > 1.5x Healthcare median of 31.93%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
50.85%
3Y equity/share CAGR > 1.5x Healthcare median of 15.79%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
81.82%
Dividend/share CAGR of 81.82% while Healthcare is zero. Walter Schloss sees a minor improvement that could compound if the firm maintains consistent raises.
77.78%
5Y dividend/share CAGR of 77.78% while Healthcare is zero. Walter Schloss sees at least some improvement that could compound over time.
45.45%
3Y dividend/share CAGR of 45.45% while Healthcare is zero. Walter Schloss sees a slight advantage if the firm is at least inching up payouts.
43.48%
AR growth of 43.48% while Healthcare median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
3.24%
Inventory growth of 3.24% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
5.71%
Asset growth of 5.71% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
3.66%
BV/share growth of 3.66% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
111.10%
Debt growth of 111.10% while Healthcare median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
-40.01%
SG&A decline while Healthcare grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.